Abstracts tagged "educational research and pediatrics"

Abstract Number: 95 • 2017 ACR/ARHP Annual Meeting
Globalisation of Paediatric Musculoskeletal Matters’ (PMM)
Nicola Smith¹, Sharmila Jandial², Ruth Wyllie², Christine English³, Barbara Davies³, Raju Khubchandani⁴, Mercedes Chan⁵, Jane Munro⁶, Virgínia Ferriani⁷, Claudia Saad Magalhães⁸, Ricardo Russo⁹, Jacqueline Yan¹⁰, Chris Scott¹¹, Sirirat Charuvanij¹², Khulood Khawaja¹³, Jelena Vojinovic¹⁴, Tim Rapley¹⁵ and Helen Foster¹⁶, ¹Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom, ²Paediatric Rheumatology, Great North Children’s Hospital, Newcastle Upon Tyne, United Kingdom, ³Department of Nursing, Midwifery and Health, Northumbria University, Newcastle Upon Tyne, United Kingdom, ⁴Department of Paediatrics, Jaslok Hospital and Research Center, Mumbai, India, ⁵Paediatric Rheumatology, University of Alberta, Edmonton, AB, Canada, ⁶Paediatric Rheumatology, Royal Children's Hospital, Victoria, Australia, ⁷Department of Paediatrics, Ribeirão Preto Medical School, University of São Paulo (USP-RP), Sao Paulo, Brazil, ⁸Department of Pediatrics, São Paulo State University (UNESP), Botucatu, Brazil, ⁹Service of Immunology/Rheumatology, Hospital de Pediatría Garrahan, Buenos Aires, Argentina, ¹⁰Paediatric Rheumatology, Starship Children’s Health, Auckland, New Zealand, ¹¹Department of Paediatrics, University of Cape Town, Cape Town, South Africa, ¹²Department of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok, Thailand, ¹³Department of Immunology/Rheumatology, Al-Mafraq Hospital, Abu Dhabi, United Arab Emirates, ¹⁴Paediatric Rheumatology, Faculty of Medicine, University of Nis, Nis, Serbia, ¹⁵Institute of Health and Society, Newcastle University, Newcastle Upon Tyne, United Kingdom, ¹⁶Institute of Cellular Medicine and Paediatric Rheumatology, Newcastle University and Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom
Background/Purpose: paediatric musculoskeletal matters’ (PMM–www.pmmonline.org) is a free, evidence-based and peer reviewed open e-resource for paediatric musculoskeletal (MSK) medicine targeting non-MSK specialists. Since launch (Nov-2014)…

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.